Additional file 8 of Combined metabolic activators improve cognitive functions in Alzheimer’s disease patients: a randomised, double-blinded, placebo-controlled phase-II trial

View Dataset
Yulug, Burak;Altay, Ozlem;Li, Xiangyu;Hanoglu, Lutfu;Cankaya, Seyda;Lam, Simon;Velioglu, Halil Aziz;Yang, Hong;Coskun, Ebru;Idil, Ezgi;Nogaylar, Rahim;Ozsimsek, Ahmet;Bayram, Cemil;Bolat, Ismail;Oner, Sena;Tozlu, Ozlem Ozdemir;Arslan, Mehmet Enes;Hacimuftuoglu, Ahmet;Yildirim, Serkan;Arif, Muhammad;Shoaie, Saeed;Zhang, Cheng;Nielsen, Jens;Turkez, Hasan;Borén, Jan;Uhlén, Mathias;Mardinoglu, Adil

Description

Additional file 8: Dataset S5. Plasma proteomics data were generated with the Olink cardiometabolic, inflammation, neurology and oncology panels for each patient before and after treatment and statistical analysis of plasma proteins between different visits or groups.

Citations (1)

Mentions (0)

Metrics

Dataset Index

2.2

FAIR Score

85%

Citations

1

Mentions

0

Metrics Over Time

Publication Details

Assigned Domain

Subfield

Immunology

Field

Immunology and Microbiology

Domain

Life Sciences

Confidence Score

58%

Source

Scholar Data Model

Keywords

BiochemistryMedicineCell BiologyNeurosciencePhysiologyFOS: Biological sciencesPharmacologyChemical Sciences not elsewhere classifiedMental Health

Normalization Factors

FT

15.38

CTw

1.00

MTw

1.00